Our in vitro experimental data indicate that SBM may be a potent modulator of obesity by repressing the PPARγ-regulated adipogenesis pathway and augmenting the TNFα-induced lipolytic and apoptotic pathway (Figure 6). The gene discussed is TNF; the disease is obesity due to melanocortin 4 receptor deficiency.